Tisdag 25 Augusti | 01:34:33 Europe / Stockholm
Est. tid*
2027-02-26 08:00 Bokslutskommuniké 2026
2026-10-20 08:00 Kvartalsrapport 2026-Q3
2026-07-21 - Kvartalsrapport 2026-Q2
2026-06-26 - Årsstämma
2026-05-08 - X-dag ordinarie utdelning PTRK 0.00 SEK
2026-04-23 - Kvartalsrapport 2026-Q1
2026-02-27 - Bokslutskommuniké 2025
2025-10-21 - Kvartalsrapport 2025-Q3
2025-07-24 - Kvartalsrapport 2025-Q2
2025-06-30 - X-dag ordinarie utdelning PTRK 0.00 SEK
2025-06-27 - Årsstämma
2025-05-13 - Kvartalsrapport 2025-Q1
2025-02-28 - Bokslutskommuniké 2024
2024-11-12 - Kvartalsrapport 2024-Q3
2024-08-13 - Kvartalsrapport 2024-Q2
2024-05-14 - Kvartalsrapport 2024-Q1
2024-05-06 - X-dag ordinarie utdelning PTRK 0.00 SEK
2024-05-03 - Årsstämma
2024-02-29 - Bokslutskommuniké 2023
2023-11-14 - Kvartalsrapport 2023-Q3
2023-08-15 - Kvartalsrapport 2023-Q2
2023-05-04 - X-dag ordinarie utdelning PTRK 0.00 SEK
2023-05-03 - Årsstämma
2023-05-02 - Kvartalsrapport 2023-Q1
2023-02-28 - Bokslutskommuniké 2022
2022-11-07 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-26 - Kvartalsrapport 2022-Q1
2022-05-04 - X-dag ordinarie utdelning PTRK 0.00 SEK
2022-05-03 - Årsstämma
2022-02-24 - Bokslutskommuniké 2021
2021-10-20 - Kvartalsrapport 2021-Q3
2021-07-28 - Kvartalsrapport 2021-Q2
LandStorbritannien
ListaFirst North Stockholm
SektorInformationsteknik
IndustriProgramvara
Physitrack är verksamt inom hälsovårdssektorn och specialiserat inom sjukgymnastik. Produktportföljen inkluderar digitala vårderbjudanden till företag via SaaS-lösningar. Utöver huvudverksamheten erbjuds även personlig service och tillhörande kringtjänster. Verksamheten drivs globalt med störst närvaro inom Europa och Nordamerika. Physitrack grundades år 2012 och har sitt huvudkontor i London.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Physitrack PLC — Transactions under Share Buy-back Programme

2026-08-24 08:30:00

Physitrack PLC (Nasdaq First North Growth Market Stockholm: PTRK) (the “Company”) announces that, in accordance with the share buy-back programme announced on 21 July 2026, it has undertaken the following transactions under the programme during the period 17–21 August 2026 (the “week”). The buy-back is carried out by Pareto Securities AB on behalf of the Company.

Summary of transactions

Period17–21 August 2026
Total shares repurchased during the week7,250
Volume-weighted average price paid (SEK)8.4483
Total consideration paid (SEK)SEK 61,250
Total shares held by the Company (treasury) following these transactions14,500
Total outstanding shares in the Company16,260,766
Treasury holding as % of issued share capital*0.089%

*Treasury holding as a percentage of issued share capital is calculated on the basis: shares held by the Company ÷ (total outstanding shares + shares held by the Company), using the most recent figures reported by Pareto Securities. Figures are rounded to the nearest SEK 0.01 / whole share where applicable.
Individual transactions

DateQuantityAverage price (SEK)
2026-08-171,5008.6667
2026-08-181,5008.5933
2026-08-191,7508.3257
2026-08-201,0008.30
2026-08-211,5008.3267

 
The buy-back programme is conducted within the safe harbour provided by Article 5 of the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and Commission Delegated Regulation (EU) 2016/1052, for the purpose of meeting the Company's obligations under its employee share plans. The programme is executed by Pareto Securities AB on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details

1. IssuerPhysitrack PLC, LEI 213800PC4QYNWHPCP774
2. Instrument / ISINOrdinary shares / GB00BYX22590
3. Trading venueNasdaq First North Growth Market Stockholm (PTRK)
4. CurrencySEK
5. Purpose of buy-backTo meet the Company's obligations under its employee share plans (a permitted purpose under Article 5(2) of MAR)
6. Executing brokerPareto Securities AB (non-discretionary mandate)

 
This information is disclosed by Physitrack PLC pursuant to Article 5 of the Market Abuse Regulation (EU) No 596/2014, as implemented by Commission Delegated Regulation (EU) 2016/1052.